Synthesis of interleukin‐1β in primary biliary cirrhosis: Relationship to treatment with methotrexate or colchicine and disease progression
Laurie C. Miller, Archna Sharma, Augusta F. McKusick, Joseph P. Tassoni, Charles A. Dinarello, Marshall M. Kaplan – 1 August 1995 – Primary biliary cirrhosis (PBC) is a chronic, progressive, cholestatic liver disease. Interleukin‐1β (IL‐1β) may play a role in the pathogenesis of PBC by contributing to altered immune function and fibrosis. Colchicine or methotrexate has some beneficial effects in the treatment of PBC, and also affects interleukin‐1 (IL‐1).